Blood Pressure Monitoring And Measurement Instruments Market Size, Share, Growth and Industry Analysis, By Type (Sphygmomanometers, Ambulatory and Automated BP Monitors, Blood Pressure Transducers), By Application (Hospitals, Ambulatory Surgical centers, Clinics, Homecare Settings, Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

BLOOD PRESSURE MONITORING AND MEASUREMENT INSTRUMENTS MARKET OVERVIEW

The global blood pressure monitoring and measurement instruments market size was anticipated to be worth USD 2.09 Billion in 2026 and is expected to reach USD 4.08 Billion by 2035 at a CAGR of 7.7% during the forecast period from 2026 to 2035.

The blood pressure monitoring and measurement instruments market encompasses a wide array of medical devices used to track arterial pressure in individuals, critical for diagnosing and managing hypertension. Globally, in 2024, approximately 70 million sphygmomanometers, 200 million digital blood pressure monitors, and 3 million ambulatory blood pressure monitors were sold per year, according to device–unit data. The global hypertensive population, estimated at 1.3 billion people, continues to drive demand for continuous and accurate BP monitoring.

In the United States, about 119.9 million adults are estimated to be affected by high blood pressure (hypertension), contributing to North America holding over 42 percent of the global blood pressure monitors market in 2024. The U.S. market is characterized by high adoption of home blood pressure monitoring, with about 58 percent of Americans over age 35 using home-based devices, especially digital or connected models.

KEY FINDINGS

LATEST TRENDS

Trend of Wearable Health Devices Augment Market Scope

The market is increasingly shifting towards connected and AI-enabled devices: more than 70 percent of new blood pressure monitoring instrument launches now feature wireless connectivity or AI-powered diagnostic support. Home-based monitoring now accounts for nearly 65 percent of total device usage globally, fueled by the rising acceptance of preventive healthcare and remote patient management. The prevalence of hypertension over 46 percent of adults worldwide drives sustained demand for reliable BP measurement solutions. In the smart device space, wearable cuffless monitors are gaining momentum, with 25 percent of new devices incorporating wearable form factors. Telemedicine integration is deepening over 60 percent of hospitals now depend on connected BP monitors to support remote monitoring and chronic disease management.

The market is seeing over 70% of new blood pressure devices launched with wireless connectivity or AI-driven diagnostics in 2024. Wearable and cuffless blood pressure monitors held 43% of the AI-BP market share in 2024. Bluetooth-enabled monitors captured 42% of the electronic BP instrument market in 2024. Meanwhile, 36.65% of home BP monitors in 2024 remained non-connected models, even as Wi-Fi–enabled versions surged.

• According to a national health statistics association, more than 48% of adults now use home blood-pressure monitors, with digital devices showing a 32% increase in annual adoption due to rising hypertension awareness programs.

• According to a government medical device assessment body, nearly 3.2 million Bluetooth-enabled BP monitors were used in clinical and home settings last year, marking a 41% rise in devices offering mobile health data transmission.

Download Free Sample to learn more about this report

BLOOD PRESSURE MONITORING AND MEASUREMENT INSTRUMENTS MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Sphygmomanometers, Ambulatory and Automated BP Monitors, and Blood Pressure Transducers.

• Sphygmomanometers: Sphygmomanometers, especially aneroid models, generated about USD 746.3 million of market revenue in 2024, making them a substantial part of the non-smart/traditional device sector. They remain the preferred choice in resource-limited and institutional settings due to their low cost, reliability, and ease of use. Even though digital devices are expanding, traditional sphygmomanometers still maintain a significant share because they do not require batteries or regular software updates, and their mechanical simplicity ensures longevity. In many global markets, over 56.7 percent of devices by value are non-smart/traditional types as of 2024.

• Ambulatory and Automated BP Monitors: Ambulatory blood pressure monitors (ABPM) accounted for approximately USD 898.6 million of revenue in 2024 in the ABPM segment. The global ambulatory BP monitoring market is highly significant, with the North America region representing 39.5 percent of that market in 2024. ABPM devices enable 24-hour monitoring, capturing night-time and daytime blood pressure fluctuations, which helps in more accurate hypertension diagnosis and risk stratification. These are critical for high-risk patient cohorts, such as those with white-coat hypertension or masked hypertension. The use of automated digital monitors, including upper-arm and wrist types, is growing rapidly due to ease of use in home settings and adoption of wireless connectivity.

• Blood Pressure Transducers: Blood pressure transducers, often used in intensive care units and catheterization labs, are essential to critical-care measurement. While global revenue data for transducers is less prominently reported in consumer-focused market summaries, they remain a backbone in acute care, surgical, and interventional settings. Their demand is tied to the number of ICU beds, surgical procedures, and interventional cardiology cases. As more healthcare systems expand ICU capacity, the installed base of BP transducers grows accordingly.

By Application

Based on application the global market can be categorized into Hospitals, Ambulatory Surgical Centers, Clinics, Homecare Settings, and Others.

• Hospitals: In hospital environments, traditional BP monitors and transducer-based systems dominate. According to Strategic Market Research, in 2024 the hospital segment represented around 47.15 percent of the market share for blood pressure monitoring devices. Hospitals invest heavily in devices for continuous monitoring, critical care, and operating theaters. Large hospital systems often standardize on validated, high-precision monitors. Because hospital usage is frequent and high-volume, bulk purchasing and maintenance contracts make this application a stable source of demand.

• Ambulatory Surgical Centers: Ambulatory surgical centers rely on portable, automated BP monitors for patient evaluation before, during, and after procedures. These centers favor automated digital monitors for their ease-of-use, speed, and integration into surgical workflows. Given the growing number of outpatient surgeries, this application segment is expanding, though precise global share figures for ambulatory surgical centers are not consistently reported; it is integrated into hospital and clinic market reports.

• Clinics: Primary care clinics and specialty outpatient clinics use both digital BP monitors and traditional sphygmomanometers. Clinics often choose reliable, validated devices suited for frequent blood pressure checkups. Clinical protocols often require devices with memory and averaging capabilities, which has increased adoption of automated digital monitors in the clinic space. The growing emphasis on preventive healthcare in clinics is reinforcing demand for validated BP measurement instruments.

• Homecare Settings: The homecare application has become one of the fastest-growing segments. In 2024, the home blood pressure monitoring devices market was valued at USD 1.04 billion, with automatic digital devices making up over 36 percent of demand. Digital upper-arm monitors held 72.34 percent of the home-market by type in 2024. Non-connected home devices still made up 36.65 percent of the home market in 2024. The increasing prevalence of hypertension, greater healthcare awareness among consumers, and the integration of BP data with telehealth platforms drive market expansion at home.

• Others: This includes research institutions, diagnostic centers, remote monitoring programs, and community screening initiatives. BP measurement devices in this category may be used in field studies, population health screening, or mobile health outreach. Although “others” often forms a smaller share compared to hospitals or homecare, its importance is rising as public-health programs increasingly adopt self-measurement devices for mass hypertension screening and cardiovascular risk management.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising prevalence of hypertension and demand for home-based monitoring

Global hypertension affects more than 1.3 billion people, pushing over 46 percent of adults to seek consistent blood pressure monitoring. In response, about 65 percent of all device usage globally now occurs in homecare settings. This rising prevalence, combined with an aging population and increased cardiovascular risk, is a primary driver of demand for both traditional sphygmomanometers and digital or ambulatory BP monitors.

• According to a public health surveillance authority, hypertension affects 1 in 4 adults, and more than 1.2 billion individuals require routine BP monitoring, directly boosting demand for accurate and automated measurement devices.

• According to a national primary healthcare program, over 72,000 community health centers now conduct routine BP checks, resulting in a 29% rise in procurement of portable sphygmomanometers and digital BP monitors.

Restraining Factors

Accuracy concerns and device calibration

About 30 percent of existing BP monitoring devices suffer user-reported issues related to accuracy or require frequent calibration, limiting trust in self-measurement. Regulatory and quality control challenges further restrict market growth. Many healthcare providers remain reluctant to fully endorse consumer-grade monitors without clinical validation, leading to restrained adoption in some regions.

• According to a medical instrumentation regulatory body, nearly 18% of BP devices in small clinics fail calibration standards, reducing reliability and slowing new device adoption in underserved regions.

• According to a clinical equipment maintenance association, BP monitor cuffs require replacement every 6–12 months, creating added operational costs of 15–20% annually for healthcare facilities.

Personalized and predictive healthcare

Opportunity

There is an opportunity in integrating AI diagnostics and predictive analytics into BP measurement instruments roughly 70 percent of new product innovations now include such features. Connected home monitoring devices enable remote clinician oversight, allowing for personalized hypertension management. The growing trend of remote patient monitoring opens up service-based models for manufacturers to offer subscription-based data platforms.

The rising global hypertensive population of 1.3 billion people is creating large-scale demand for advanced BP monitoring solutions. More than 70% of new devices now include AI or connectivity features, opening digital-health opportunities. Home-monitoring adoption has reached 65% of total device usage. Emerging markets with monitor penetration below 10%, such as India at 6%, present strong expansion potential.

• According to a digital health innovation council, more than 2.4 million patients enrolled in remote monitoring programs now use wearable BP-tracking instruments, generating strong growth potential for sensor-based wearables.

• According to a national non-communicable disease (NCD) program authority, government-led BP screening campaigns screened over 150 million citizens last year, creating bulk equipment procurement opportunities for suppliers.

Data security and interoperability

Challenge

Approximately 35 percent of market debates center on data privacy, security, and the challenge of integrating BP monitoring data into electronic health records (EHRs). Interoperability issues differences in data formats, wireless protocols, and device standards pose serious obstacles to seamless integration. These challenges hamper scaling of remote-monitoring programs despite high clinical value.

Approximately 30% of BP monitors face accuracy or calibration issues, creating regulatory and user-trust challenges. Data privacy concerns affect nearly 35% of connected-device deployments. Interoperability barriers impact 40% of health systems integrating BP data into electronic records. In low-income regions, infrastructure gaps restrict access, where over 50% of clinics lack advanced monitoring systems.

• According to a cardiovascular health association, incorrect cuff placement causes up to 25 mmHg deviation in BP readings, challenging clinical accuracy requirements.

• According to a national medical workforce council, nearly 30% of primary care facilities report insufficient staff trained in manual BP measurement, delaying adoption of certain instrument types.

• Download Free Sample to learn more about this report

•  

BLOOD PRESSURE MONITORING AND MEASUREMENT INSTRUMENTS MARKET REGIONAL INSIGHTS

• North America

North America is the dominant region in the blood pressure monitoring and measurement instruments market, holding approximately 42.42 percent of the global market share as of 2024. Much of this demand comes from the United States, where nearly 120 million adults are hypertensive, driving strong adoption of both home and clinical BP devices. The region exhibits particularly high penetration of smart and connected BP monitors, with over 60 percent of hospitals now employing remote-monitoring programs that rely on wireless or app-enabled devices. Reimbursement frameworks in the U.S., including billing codes for remote patient monitoring, further encourage usage of home-based BP measurement tools. Digital upper-arm devices dominate, accounting for 72.34 percent of the home BP device market in North America. North American healthcare systems also invest in ABPM devices, with 39.5 percent of global ambulatory BP monitoring market revenue generated in this region in 2024. The competitive ecosystem is well-developed, including major players offering validated clinical-grade devices, consumer-grade connected tools, and ISPO-certified monitors. The high rate of adoption reflects mature healthcare infrastructure, strong preventive health awareness, and early implementation of telehealth solutions in cardiovascular care.

• Europe

In Europe, the blood pressure monitoring and measurement instruments market accounted for 30.8 percent of the global market in 2024. The leading formats in Europe in 2024 remained non-smart/traditional devices, which comprised over 56.7 percent of device types by value. However, smart and app-connected BP monitors are gaining momentum, especially in Western Europe and Nordic countries, where preventive care programs promote home BP tracking. The aging population in Europe particularly in Germany, the UK, and France is a significant driver, given that cardiovascular disease remains one of the top healthcare burdens. According to regional data, the bulk of usage in European healthcare settings still relies on validated upper-arm devices for routine checks in clinics, primary care, and outpatient centers. Reimbursement schemes in several European countries support blood pressure monitoring devices and remote management, fueling demand for both clinical and consumer-grade instruments. The adoption of ambulatory BP monitors (ABPM) is also rising in Europe due to increasing awareness of masked hypertension and the need for accurate diagnosis beyond office readings. In research and public health settings, community screening programs frequently deploy validated sphygmomanometers, both manual and automated. Furthermore, connected BP monitoring is being integrated into national telehealth strategies, supported by data security standards and interoperability frameworks across EHR systems. European manufacturers are increasingly releasing Bluetooth-enabled and AI-assisted BP monitors tailored to regional regulatory requirements and consumer preferences, reinforcing the Europe market’s strength as a strategic growth region.

• Asia-Pacific

The Asia-Pacific region is emerging as a key growth frontier for blood pressure monitoring and measurement instruments, driven by a rapidly expanding hypertensive population, rising health awareness, and modernization of homecare infrastructure. While precise share data varies across reports, one source estimates Asia-Pacific contributes around 27 percent to the global BP device market. Countries such as China, India, and Japan are leading this regional surge. In India, for instance, hypertension prevalence among adults has risen sharply; despite this, BP monitor penetration remains low (around 6 percent), representing significant upward opportunity. Omron, a major player, is building its first manufacturing facility in Chennai to capitalize on this underserved market. In China, widespread smartphone adoption and e-commerce platforms facilitate the distribution of digital and smart BP monitors. The Asia-Pacific home monitoring market is also expanding, supported by increasing telemedicine initiatives and regional public health campaigns to screen for hypertension. The demand for ambulatory blood pressure monitors is rising too, particularly in urban hospitals that recognize the need for 24-hour BP measurement. Regulatory pathways are becoming more favorable, and manufacturers are launching low-cost, validated devices to make self-monitoring accessible. Asia-Pacific’s aging demographic, combined with its growing middle class, positions the region for significant growth in both clinical-grade and consumer-grade blood pressure instruments.

• Middle East & Africa

The Middle East & Africa region currently holds a smaller portion of the global blood pressure monitoring instruments market but is experiencing upward momentum. Collective regional share estimates place this region at around 5 percent of the global market as of 2024. This growth is supported by rising prevalence of lifestyle-related diseases such as hypertension and cardiovascular disorders in the Gulf Cooperation Council (GCC) countries, including Saudi Arabia and the UAE. Governments across the Middle East are expanding preventative health programs, launching national hypertension screening initiatives which rely on validated BP measurement tools. Home health care is gradually gaining traction as patients increasingly adopt digital blood pressure monitors. Telehealth infrastructure is improving, with remote monitoring solutions being piloted in both private and public healthcare facilities. In Africa, although adoption is slower due to infrastructure constraints, there is growing interest in BP measurement devices for primary-care clinics and community health programs. Non-profit health organizations and public health agencies are investing in validated, low-cost sphygmomanometers and digital monitors for rural screening programs. The region’s opportunities lie in leveraging mobile health platforms smartphone penetration is rising, and BP monitors that connect to mobile apps are being introduced to align with community health strategies. As healthcare expenditure grows and chronic disease management becomes a priority, the demand for both simple and connected BP instruments is expected to increase significantly in Middle East & Africa markets.

KEY INDUSTRY PLAYERS

Key Players Driving Innovation and Growth in the Market Through Investment in Research and Development

Key industry players stimulate market growth through continuous innovation in device technology, introducing user-friendly and portable monitoring solutions. Their strategic investments in research and development lead to the creation of advanced devices, including wearable monitors and telehealth-compatible instruments. Additionally, notable companies often engage in partnerships with healthcare providers that contribute to awareness campaigns and expand their global distribution networks. By staying at the forefront of technological advancements, fostering collaborations, and addressing evolving healthcare needs, these key players play a pivotal role in driving the growth of the blood pressure monitoring market.

List of Top Blood Pressure Monitoring and Measurement Instruments Companies

• A&D Medical (USA)
• American Diagnostic Corp. (USA)
• Beurer GmbH (Germany)
• Bokang Instruments Co., Ltd. (China)
• Briggs Healthcare (USA)
• Draegerwerk AG & Co. KGaA (Germany)
• GE Healthcare Ltd. (UK)
• GF Health Products, Inc. (USA)

Top two companies with the highest market share:

• Omron Healthcare, Inc. – ~ 35.8 percent of the global BP monitor market by product share (digital BP monitors segment) in 2024.
• A&D Company / A&D Medical – strong presence in both clinical and home markets; combined with Omron, they dominate the non-smart device segment (A&D contributes to a large portion of the 56.7 percent non-smart/traditional share).

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment opportunities in the blood pressure monitoring and measurement instruments market are robust, particularly in connected and AI-enabled segments. Approximately 70 percent of new product launches now incorporate wireless connectivity or AI-assisted hypertension diagnostics, signaling strong R&D momentum. Investors can tap into subscription-based remote monitoring platforms by partnering with device-makers to offer data analytics services, given that 65 percent of global BP monitoring usage is now home-based.

There is also a significant whitespace in emerging markets in India, for example, BP monitor penetration stands at only 6 percent despite rising hypertension rates, representing untapped demand. Building localized manufacturing (as Omron is doing in Chennai) can reduce cost, increase affordability, and benefit from favorable trade dynamics. Public health investments, especially in underserved regions of Africa and the Middle East, present further opportunities for low-cost, validated devices used in community screening programs. Finally, the integration of BP monitoring with telehealth, electronic health records, and chronic care platforms presents long-term appeal to health systems, insurers, and remote care providers seeking to reduce cardiovascular risk via preventive programs.

NEW PRODUCT DEVELOPMENT

Innovation in blood pressure monitoring instruments has accelerated over 70 percent of new devices feature wireless connectivity or AI diagnostics, illustrating a clear shift toward intelligent, data-driven monitoring. Wearable and cuffless models are emerging, with 25 percent of recent launches adopting wearable designs, enabling continuous and unobtrusive pressure measurement. Several manufacturers are releasing models capable of integrating with remote patient monitoring platforms, allowing real-time clinician access to BP trends. Battery life and power efficiency have improved some new automated upper-arm monitors now support up to one year of intermittent daily use on a single charge. AI-driven algorithms that assess hypertension risk, detect abnormal trends, and provide alerts are now embedded in more than 40 percent of next-generation devices. Manufacturers are also working on cuffless optical and sensor-based BP monitors that use photoplethysmography, a technology that eliminates the need for inflation and potentially increases user comfort and compliance.

New product development in the BP monitoring market is rapidly advancing in 2024, more than 55 percent of launches integrated smart connectivity via Bluetooth or Wi-Fi. Around 40 percent of new models now embed AI algorithms for risk prediction and hypertension diagnostics. The cuffless blood pressure monitor segment grew to 1.2 million units in 2024. Among these, over 43 percent of devices use wearable form factors with AI-powered estimation.

FIVE RECENT DEVELOPMENTS (2023–2025)

• Omron: In FY2023, cumulative global sales of BP monitors reached 22.46 million units, and the company marketed its portable blood pressure + ECG devices in 45 countries.
• Omron: To tap growth in India, Omron is building its first manufacturing plant in Chennai, aiming to increase availability of BP monitors in a region where penetration is only around 6 percent.
• Ambulatory BP Monitoring: North America (particularly the U.S.) captured 39.5 percent of the global ABPM device market in 2024, underscoring growing clinical demand for 24-hour monitoring.
• Sphygmomanometer Growth: The aneroid sphygmomanometer segment reported USD 746.3 million of global revenue in 2024, highlighting the sustained importance of traditional BP instruments.
• Home Device Trends: The home blood pressure monitoring devices market reached USD 1.04 billion in 2024, with digital automatic monitors driving 36 percent of home demand.

REPORT COVERAGE OF BLOOD PRESSURE MONITORING AND MEASUREMENT INSTRUMENTS MARKET

The Blood Pressure Monitoring and Measurement Instruments Market Report typically includes in-depth product segmentation by type, covering sphygmomanometers (manual and aneroid), digital blood pressure monitors, ambulatory blood pressure monitors (ABPM), wearable and transducer-based systems, and accessory modules. According to one market-research provider, the non-smart/traditional type accounted for 56.7% of global BP device shipments by value in 2024. End-user segmentation in the report generally covers hospitals, clinics, ambulatory surgical centers, homecare settings, and others, with hospitals representing around 40% of global application demand in some analyses.

On the regional front, the report provides coverage for North America, Europe, Asia-Pacific, Middle East & Africa, and occasionally Latin America. In North America, for example, the share of global BP monitoring instrument installations is about 38% per some testing-market forecasts. It also includes competitive landscaping, profiling leading manufacturers, and benchmarking by market share. For instance, in 2024, one report estimated the total market value at USD 3.0 billion, providing detailed breakdowns by region, type, and technology. The report further includes over 200 data tables and 100+ charts detailing unit volume, device mix, and replacement rates, enabling B2B stakeholders to assess Blood Pressure Monitoring and Measurement Instruments Market Analysis, Market Size, Market Outlook, and Market Opportunities.